The results are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. Our funding sources are as follows. J.N.K.: RWTH University Aachen (START 2018-691906). V.S.: Breast Cancer Now, P.Bo: DFG: (SFB/TRR57, SFB/TRR219, BO3755/3-1, and BO3755/6-1), the German Ministry of Education and Research (BMBF: STOP-FSGS-01GM1901A) and the German Ministry of Economic Affairs and Energy (BMWi: EMPAIA project). A.T.P.: NIH/NIDCR (#K08-DE026500), Institutional Research Grant (#IRG-16-222-56) from the American Cancer Society, Cancer Research Foundation Research Grant, and the University of Chicago Med470 icine Comprehensive Cancer Center Support Grant (#P30-CA14599). T.L.: Horizon 2020 through the European Research Council (ERC) Consolidator Grant PhaseControl (771083), a Mildred Scheel-Endowed Professorship from the German Cancer Aid (Deutsche Krebshilfe), the German Research Foundation (DFG) (SFB CRC1382/P01, SFB-TRR57/P06, LU 1360/3-1), the Ernst-Jung Foundation Hamburg and the IZKF (interdisciplinary center of clinical research) at RWTH Aachen.
Correction to: Nature Cancer https://doi.org/10.1038/s43018-020-0087-6, published online 27 July 2020. https://doi.org/10.1038/s43018-020-00149-6
FingerprintDive into the research topics of 'Pan-cancer image-based detection of clinically actionable genetic alterations'. Together they form a unique fingerprint.
- School of Medicine, Medical Sciences & Nutrition, Molecular and Cellular Function
- School of Medicine, Medical Sciences & Nutrition, Medical Sciences - Chair in Molecular Oncology
- School of Medicine, Medical Sciences & Nutrition, Institute of Medical Sciences
- School of Medicine, Medical Sciences & Nutrition, Aberdeen Cancer Centre